Piper Sandler Reiterates Overweight Rating on Nurix (NRIX)

April 10, 2026 8:50 AM

Piper Sandler analyst Biren Amin reiterated an Overweight rating and $35.00 price target on Nurix (NASDAQ: NRIX).The analyst commented: "Earlier ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found